$CLBT

Barter David sold $683K of CLBT

Barter David (Chief Financial Officer) sold 41,734 shares of Cellebrite DI Ltd. (CLBT) at $16.38 ($0.68M total) on 2026-07-08.

Original reporting
SEC EDGAR · Barter David
Published Jul 9, 2026, 8:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 9, 2026, 8:16 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CLBT
Neutral
medium confidence
Mentioned
$CLBT
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CLBTNeutralLow
01

Why it matters

The newest fact is the specific sale details (shares, price, total value, and holdings after sale) plus the note that there was no pre-arranged 10b5-1 plan.

02

Market read

Traders may monitor CLBT for follow-on insider activity, but this single Form 4 sale alone is unlikely to drive a durable repricing.

03

What to watch

The article does not state the insider’s total compensation, tax obligations, or whether other sales occurred, so interpreting directionality for fundamentals is risky.

Relevance 5/10Novelty 3/10Timing: after-hours/next-session context from a newly filed Form 4 (filed 2026-07-09)

Background

The article is an SEC Form 4 insider transaction disclosure for Cellebrite DI Ltd., reporting an open-market sale by the CFO.

Company-level read

Ticker impact

$CLBTNeutralMedium confidence
Context

Cellebrite CFO Barter David sold 41,734 shares on 2026-07-08 at $16.3756, totaling $683,419.29, per Form 4.

Expected impact

Likely limited near-term price impact; any effect is sentiment-driven and typically fades unless accompanied by other disclosures.

Evidence & confidence

The filing provides transaction size, price, and post-sale holdings, but does not include new company performance, guidance, or legal/regulatory developments.

Market effects

No clear sector read-across; insider sales are company-specific and often non-informational.

None.

None.

Counterpoint

Insider sales can be planned for liquidity or diversification and may not reflect negative fundamentals, especially when the filing is a standard open-market transaction.

Key entities

  • Cellebrite DI Ltd.

    US-listed company (CLBT) whose CFO filed an insider sale on Form 4.

  • Barter David

    Chief Financial Officer who sold 41,734 shares on 2026-07-08.

Related articles